Effects of ethanolic extract of pine needles (Pinus eldarica Medw.) on reserpine-induced depression-like behavior in male Wistar rats

Pharmacognosy Magazine

Volumn 7, Issue 27, 2011, Pages 248-253

  Bolandghamat, Samira ^a   Moghimi, Ali ^a   Iranshahi, Mehrdad ^b  

^a FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antidepressant activity; depression; forced swimming test; open field test; Pinus eldarica Medw.; reserpine

Indexed keywords

ANTIDEPRESSANT AGENT; IMIPRAMINE; PINUS ELDARICA EXTRACT; PLANT EXTRACT; RESERPINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONIFER NEEDLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG SCREENING; EXPERIMENTAL RAT; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; NONHUMAN; OPEN FIELD TEST; PINE; PINUS ELDARICA; RAT;

EID: 80052771247     PISSN: 09731296     EISSN: 09764062     Source Type: Journal    
DOI: 10.4103/0973-1296.84240     Document Type: Article

References (40)

1. Blazer DG. Mood disorders: Epidemiology. In: Sadock BJ, editor. Comprehensive textbook of psychiatry, 7st ed. New York: Lippincott Williams and Wilkins; 2000. p. 1298-308.
2. Anisman H, Zacharko RM. Depression: The predisposing influence of stress. Behav Brain Sci 1982;5:89-137.
3. Fava M, Kendler KS. Major depressive disorder. Neuron 2000;28:335-41.
4. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006;354:579-87. (Pubitemid 43209105)
5. Markowitz JS, Donovan JL, DeVane CL, Taylor RM, Ruan Y, Wang JS, et al. Effect of St. John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003;290:1500-4. (Pubitemid 37430406)
6. Michelozzi M, Tognetti R, Maggino F, Radicati M. Seasonal variations in monoterpene profiles and ecophysiological traits in Mediterranean pine species of group "halepensis". iForest 2008;1:65-74.
7. Mamedov N, Craker LE. Medicinal plants used for the treatment of bronchial asthma in Russia and Central Asia. J Herbs Spices Med Plants 2001;8:91-117. (Pubitemid 33009272)
8. Mamedov N, Gardner Z, Craker LE. Medicinal plants used in Russia and Central Asia for the treatment of selected skin conditions. J Herbs Spices Med Plants 2005;11:191-222.
9. Lee E. Effect of powdered pine needle (Pinus densiflora Sieb et Zucc.) on serum and liver lipid composition and antioxidative capacity in rats fed high oxidative fat. J Korean Soc Food Sci Nutr 2003;32:926-30. (Pubitemid 37283234)
10. Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol®): A herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 2002;40:158-68. (Pubitemid 34296383)
11. Guri A, Kefalas P, Roussis V. Antioxidant potential of six pine species. Phytother Res 2006;20:263-6.
12. Vuorela S, Kreander K, Karonen M, Nieminen R, Hämäläinen M, Galkin A, et al. Preclinical evaluation of rapeseed, raspberry, and pine bark phenolics for health related effects. J Agric Food Chem 2005;53:5922-31. (Pubitemid 41126626)
13. Li K, Li Q, Li J, Gao D, Zhang T, Han Z, et al. Effect of procyanidins from Pinus koraiensis bark on growth inhibition and expression of PCNA and TNF-a in mice with U14 cervical cancer. Therapy 2007;4:685-90. (Pubitemid 47591317)
14. Potta SP, Doss MX, Hescheler J, Sachinidis A. Epigallocatechin- 3-gallate (EGCG): A structural target for the development of potential therapeutic drugs against anti-proliferative diseases. Drug Design Rev Online 2005;2:85-91. (Pubitemid 41364606)
15. Karonen M, Hämäläinen M, Nieminen R, Klika KD, Loponen J, Ovcharenko VV, et al. Phenolic extractives from the bark of Pinus sylvestris L. and their effects on inflammatory mediators nitric oxide and prostaglandin E2. J Agric Food Chem 2004;52: 7532-40.
16. Shashi B, Jaswant S, Madhusudana RJ, Kumar SA, Nabi QG. A novel lignan composition from Cedrus deodara induces apoptosis and early nitric oxide generation in human leukemia Molt-4 and HL-60 cells. Nitric Oxide 2006;14:72-88. (Pubitemid 43063511)
17. Virgili F, Kobuchi H, Packer L. Nitrogen monoxide (NO) metabolism: Antioxidant properties and modulation of inducible NO synthase activity in activated macrophages by procyanidins extracted from Pinus maritime (Pycnogenol®). In: Rice-Evans CA, editor. Flavonoids in Health and Disease, New York: Marcel Dekker Inc.; 1998. p. 421-36.
18. Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol 1978;47:379-91.
19. Detke MJ, Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: The effects of water depth. Behav Brain Res 1996;73:43-6. (Pubitemid 26007585)
20. Kandel ER. Disorders of mood: Depression, mania, and anxiety disorders. In: Kandel ER, editor. Principles of neural science, 4st ed. New York: McGraw-Hill Companies; 2000. p. 1216-7.
21. Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review. Eur J Pharmacol 2003;463:3-33. (Pubitemid 36205070)
22. Myron A, Hoffer MD. Effects of reserpine and amphetamine on the development of hyperactivity in maternally deprived rat pups. Psychosom Med 1980;42:513-20.
23. O'Gara BA, Chae H, Latham LB, Friesen WO. Modification of leech behavior patterns by reserpine-induced amine depletion. J Neurosci 1991;11:96-110.
24. Gluckman MI. Reserpine stimulation in mice. Fedn Proc Fedn Am Socs Exp Biol 1964;23:197.
25. Magus RD, Krause FW, Riedel BE. Dissociation of reserpineinduced depression of spontaneous motor activity and release of brain serotonin in rats. Biochem Pharmacol 1964;13:943-7.
26. Kaundun SS, Lebreton P, Fady B. Genetic differences between Pinus halepensis, Pinus brutia and Pinus eldarica based on needle flavonoids. Biochem Syst Ecol 1997;25:553-62. (Pubitemid 27430705)
27. Paulke A, Schubert-Zsilavecz M, Wurglics M. Determination of St. John's wort flavonoid-metabolites in rat brain through high performance liquid chromatography coupled with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2006;832:109-13. (Pubitemid 43213017)
28. Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 2004;36:592-604. (Pubitemid 38230176)
29. Graf BA, Ameho C, Dolnikowski GG, Milbury PE, Chen CY, Blumberg JB. Quercetin metabolism in the gastrointestinal tract of the rat. J Nutr 2006;136:39-44. (Pubitemid 43156482)
30. Kawabata K, Kawai Y, Terao J. Suppressive effect of quercetin on acute stress-induced hypothalamic-pituitary-adrenal axis response in Wistar rats. J Nutr Biochem 2010;21:374-80.
31. Sakakibara H, Ishida K, Grundmann O, Nakajima J, Seo S, Butterweck V, et al. Antidepressant effect of extracts from Ginkgo biloba leaves in behavioral models. Biol Pharm Bull 2006;29:1767-70. (Pubitemid 44166388)
32. Hosseinzadeh H, Motamedshariaty V, Hadizadeh F. Antidepressant effect of kaempferol, a constituent of saffron (Crocus sativus) petal, in mice and rats. Pharmacologyonline 2007;2:367-70. (Pubitemid 47408666)
33. Dimpfel W. Rat electropharmacograms of the flavonoids rutin and quercetin in comparison to those of moclobemide and clinically used reference drugs suggest antidepressive and/or neuroprotective action. Phytomedicine 2009;16:287-94.
34. Hou Y, Aboukhatwa MA, Lei DL, Manaye K, Khan I, Luo Y. Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice. Neuropharmacology 2010;58:911-20.
35. Fehske CJ, Leuner K, Müller WE. Ginkgo biloba extract (EGb761®) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment. Pharmacol Res 2009;60:68-73.
36. Saaby L, Rasmussen HB, Jäger AK. MAO-A inhibitory activity of quercetin from Calluna vulgaris (L.) Hull. J Ethnopharmacol 2009;121:178-81.
37. Chimenti F, Cottiglia F, Bonsignore L, Casu L, Casu M, Floris C, et al. Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: Extraction, biological analysis, and computational study. J Nat Prod 2006;69:945-9. (Pubitemid 44166270)
38. Han XH, Hong SS, Hwang JS, Lee MK, Hwang BY, Ro JS. Monoamine oxidase inhibitory components from Cayratia japonica. Arch Pharm Res 2007;30:13-7.
39. Billett EE. Monoamine oxidase (MAO) in human peripheral tissues. Neurotoxicology 2004;25:139-48. (Pubitemid 38044175)
40. Yamada M, Yasuhara H. Clinical pharmacology of MAO inhibitors: Safety and future. Neurotoxicology 2004;25:215-21. (Pubitemid 38044183)